Conjuchem announces VP finance promotion
This article was originally published in Scrip
Executive Summary
ConjuChem Biotechnologies, a Canadian biotechnology company developing drugs from therapeutic peptides, has promoted Chantal Lapointe to vice-president of finance. Mrs Lapointe, who previously held the role of director of finance and administration at the company, has been with ConjuChem for the past 11 years. ConjuChem has also confirmed that Lennie Ryer, vice-president and chief financial officer, left the company on May 15th.